Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Beside its effects on T cells, a direct influence on cells of the myelo-monocytic lineage by GA becomes evident. Recently, we demonstrated that GA drives microglia to adopt properties of type II antigen presenting cells (APC) and increases their phagocytic activity. In the present work, we focused o...
Main Authors: | Refik Pul, Franco Morbiducci, Jelena Škuljec, Thomas Skripuletz, Vikramjeet Singh, Ute Diederichs, Niklas Garde, Elke Verena Voss, Corinna Trebst, Martin Stangel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3527448?pdf=render |
Similar Items
-
Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment?
by: Elke Verena Voß, et al.
Published: (2012-01-01) -
CSF Levels of Angiopoietin-2 Do Not Differ between Patients with CSF Fluid Leakage Syndrome and Controls
by: Refik Pul, et al.
Published: (2015-01-01) -
Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis
by: Elke Voss, et al.
Published: (2011-03-01) -
Physicochemical and Biological Examination of Two Glatiramer Acetate Products
by: Arthur Komlosh, et al.
Published: (2019-07-01) -
The role of glatiramer acetate in the early treatment of multiple sclerosis
by: David W Brandes
Published: (2010-06-01)